Biologics Research Review, Issue 40 - Gastroenterology focus

In this issue:

Anti-TNF therapy and mortality in veterans with IBD
Anti-SARS-CoV-2 antibody responses in IBD with infliximab
TNF antagonists in older patients with UC
Peak and intermediate infliximab levels predict IBD remission
Golimumab and work productivity in moderate-to-severe UC
Histological remission in UC patients receiving adalimumab
Vedolizumab effects on COVID-19 outcomes in IBD
Vedolizumab and anti-TNF-α in biologic-naive IBD
Anti-TNF proactive TDM program in paediatric IBD
Anti-TNF therapy for preventing the recurrence of CD
Pregnancy and neonatal outcomes after biologics and thiopurines

Please login below to download this issue (PDF)

Subscribe